Bhaskar Chaudhuri, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 20,000 shares at $30.77 ($622K) on 2021-03-22, disclosed to the SEC on 2021-03-24.
Open-market sale of $622k ARQT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.77 | 5,008 | $154K | 24.8% |
| 2 | $30.77 | 5,008 | $154K | 24.8% |
| 3 | $31.43 | 4,992 | $157K | 25.2% |
| 4 | $31.43 | 4,992 | $157K | 25.2% |
| Total | $31.10 avg | 20,000 | $622K | 100% |
| Filing → |
| ARQT | SELL | 2021-06-03 | $275K | — | Filing → |
| ARQT | SELL | 2021-05-19 | $525K | — | Filing → |
| ARQT | SELL | 2021-02-24 | $710K | — | Filing → |